Creso Pharma Limited

COPHFOTCHealthcare

$0.12

+$0.00(+0.00%)

Market Cap$131722112

P/E Ratio—

52W High—

52W Low—

Avg Volume1

Open$0.00

Beta-24.81

Earnings Financials Revenue

Creso Pharma Limited (COPHF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

COPHF · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2023Report Date: Jun 30, 2023

EPS Actual

-$5.18

Revenue

$0.00B

Fiscal Period

Q2 FY2023

FY ends December

Report Date

Jun 30, 2023

After Market Close

COPHF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2025	May 30, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Feb 26, 2025	—	—	—	—	—	—
◌ Q4 FY2024	Oct 21, 2024	—	—	—	—	—	—
◌ Q3 FY2024	Aug 29, 2024	—	—	—	—	—	—
◌ Q2 FY2024	Apr 30, 2024	—	—	—	—	—	—
◌ Q1 FY2024	Feb 29, 2024	—	—	—	$0.01B	—	—
— Q2 FY2023	Jun 30, 2023	—	-$5.18	—	$0.00B	—	—
— Q4 FY2022	Dec 31, 2022	—	-$6.87	—	$0.00B	—	—

Q2 FY2025

May 30, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Feb 26, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Oct 21, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Aug 29, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

Apr 30, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Feb 29, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Q2 FY2023

Jun 30, 2023

EPS Actual

-$5.18

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2022

Dec 31, 2022

EPS Actual

-$6.87

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for COPHF.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2023	Jun 30, 2023	—	$8.46	$8.46	+0.00%
— Q4 FY2022	Dec 31, 2022	—	$3.72	$3.72	+0.00%
— Q2 FY2022	Jun 30, 2022	—	$15.93	$18.63	+16.95%
— Q4 FY2019	Dec 31, 2019	—	$2.60	$2.60	+0.00%
— Q2 FY2019	Jun 30, 2019	—	$0.01	$0.02	+9.09%
— Q4 FY2018	Dec 31, 2018	—	$0.03	$0.03	+0.00%

Q2 FY2023+0.00%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$8.46

Price After

$8.46

Q4 FY2022+0.00%

Report Date

Dec 31, 2022

EPS Beat/Miss

—

Price Before

$3.72

Price After

$3.72

Q2 FY2022+16.95%

Report Date

Jun 30, 2022

EPS Beat/Miss

—

Price Before

$15.93

Price After

$18.63

Q4 FY2019+0.00%

Report Date

Dec 31, 2019

EPS Beat/Miss

—

Price Before

$2.60

Price After

$2.60

Q2 FY2019+9.09%

Report Date

Jun 30, 2019

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.02

Q4 FY2018+0.00%

Report Date

Dec 31, 2018

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Beat Rate0 / 6 quarters

Largest Move+16.95% (Q2 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Creso Pharma Limited (COPHF) most recently reported earnings on June 30, 2023 for Q2 FY2023, posting EPS of $-5.18 (in line with the analyst consensus of —). The next COPHF earnings date is expected around September 1, 2026.

Each quarter, investors track COPHF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. COPHF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

COPHF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

COPHF earnings · 4 questions

Creso Pharma Limited's next earnings report is expected around September 1, 2026. COPHF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; COPHF historically reports after market close (AMC).

COPHF earnings datewhen is COPHF earningsCOPHF next earnings datewhen does COPHF report earningsCOPHF earnings calendar

▸ Source: FMP · Creso Pharma Limited SEC filings · US GAAP · Creso Pharma Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026